These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1562019

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of platelet activating factor-induced aggregation and secretion in human platelets.
    McCulloch RK, Vandongen R.
    Prostaglandins; 1990 Jan; 39(1):13-21. PubMed ID: 2106712
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R, Mezzasoma AM, Venditti G, Gresele P.
    Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
    [Abstract] [Full Text] [Related]

  • 5. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA, Jones RL, Peesapati V, Will SG, Wilson NH.
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Action of platelet-activating factor on type 1 diabetic human platelets.
    Greco NJ, Arnold JH, O'Dorisio TM, Cataland S, Panganamala RV.
    J Lab Clin Med; 1985 Apr; 105(4):410-6. PubMed ID: 3981054
    [Abstract] [Full Text] [Related]

  • 9. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
    Morris DD, Moore JN.
    Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
    [Abstract] [Full Text] [Related]

  • 10. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D, Morzenti G, Livio M, Morelli C, Cassina G, Remuzzi G.
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration.
    Violi F, Pratico D, Ghiselli A, Alessandri C, Iuliano L, Cordova C, Balsano F.
    Atherosclerosis; 1990 Jun; 82(3):247-52. PubMed ID: 2115784
    [Abstract] [Full Text] [Related]

  • 12. Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine.
    Shah BH, Rasheed H, Rahman IH, Shariff AH, Khan FL, Rahman HB, Hanif S, Saeed SA.
    Exp Mol Med; 2001 Dec 31; 33(4):226-33. PubMed ID: 11795484
    [Abstract] [Full Text] [Related]

  • 13. Thromboxane A2 and platelet-activating factor decrease in the platelet-mesangial cell interactions.
    Arribas I, Rodríguez-Puyol D, García-Escribano MC, Díez-Marques ML, Pérez de Lema G, Rodríguez-Puyol M.
    Life Sci; 1995 Dec 31; 57(10):957-65. PubMed ID: 7643720
    [Abstract] [Full Text] [Related]

  • 14. Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes.
    Korth R, Riess H, Brehm G, Hiller E.
    Thromb Res; 1986 Mar 01; 41(5):699-706. PubMed ID: 3961742
    [Abstract] [Full Text] [Related]

  • 15. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
    Cattaneo M, Canciani MT, Mannucci PM.
    Thromb Haemost; 1985 Apr 22; 53(2):221-4. PubMed ID: 3927505
    [Abstract] [Full Text] [Related]

  • 16. Involvement of thromboxane A2 and tyrosine kinase in the synergistic interaction of platelet activating factor and calcium ionophore A23187 in human platelet aggregation.
    Rasheed H, Saeed SA.
    Exp Mol Med; 2004 Jun 30; 36(3):220-5. PubMed ID: 15272233
    [Abstract] [Full Text] [Related]

  • 17. Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity.
    Hirakata H, Ushikubi F, Toda H, Nakamura K, Sai S, Urabe N, Hatano Y, Narumiya S, Mori K.
    Anesthesiology; 1996 Dec 30; 85(6):1447-53. PubMed ID: 8968193
    [Abstract] [Full Text] [Related]

  • 18. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.
    Di Minno G, Martinez J, McKean ML, De La Rosa J, Burke JF, Murphy S.
    Am J Med; 1985 Nov 30; 79(5):552-9. PubMed ID: 3933340
    [Abstract] [Full Text] [Related]

  • 19. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV, Rogers RC, Loadholt CB, Colwell JA.
    J Lab Clin Med; 1981 Jan 30; 97(1):87-96. PubMed ID: 7452084
    [Abstract] [Full Text] [Related]

  • 20. Effects of tetrandrine and fangchinoline on human platelet aggregation and thromboxane B2 formation.
    Kim HS, Zhang YH, Fang LH, Yun YP, Lee HK.
    J Ethnopharmacol; 1999 Aug 30; 66(2):241-6. PubMed ID: 10433485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.